6926 related articles for article (PubMed ID: 2654956)
1. Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside.
Houghton AN; Bajorin DF; Lonberg M; Chapman P
Prog Clin Biol Res; 1989; 288():383-90. PubMed ID: 2654956
[No Abstract] [Full Text] [Related]
2. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside.
Nasi ML; Meyers M; Livingston PO; Houghton AN; Chapman PB
Melanoma Res; 1997 Aug; 7 Suppl 2():S155-62. PubMed ID: 9578432
[TBL] [Abstract][Full Text] [Related]
3. Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
Kirkwood JM; Mascari RA; Edington HD; Rabkin MS; Day RS; Whiteside TL; Vlock DR; Shipe-Spotloe JM
Cancer; 2000 Jun; 88(12):2693-702. PubMed ID: 10870051
[TBL] [Abstract][Full Text] [Related]
4. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
[TBL] [Abstract][Full Text] [Related]
5. Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies.
Yao TJ; Meyers M; Livingston PO; Houghton AN; Chapman PB
Clin Cancer Res; 1999 Jan; 5(1):77-81. PubMed ID: 9918205
[TBL] [Abstract][Full Text] [Related]
6. Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant.
McCaffery M; Yao TJ; Williams L; Livingston PO; Houghton AN; Chapman PB
Clin Cancer Res; 1996 Apr; 2(4):679-86. PubMed ID: 9816218
[TBL] [Abstract][Full Text] [Related]
7. Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells.
Dippold WG; Knuth A; Meyer zum Büschenfelde KH
Behring Inst Mitt; 1984 May; (74):14-8. PubMed ID: 6332614
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse.
Ritter G; Boosfeld E; Calves MJ; Oettgen HF; Old LJ; Livingston PO
Immunobiology; 1990 Dec; 182(1):32-43. PubMed ID: 2098322
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical models for immunotherapy of melanoma.
Reisfeld RA
Prog Clin Biol Res; 1989; 288():183-93. PubMed ID: 2654950
[No Abstract] [Full Text] [Related]
10. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
Welt S; Carswell EA; Vogel CW; Oettgen HF; Old LJ
Clin Immunol Immunopathol; 1987 Nov; 45(2):214-29. PubMed ID: 3665201
[TBL] [Abstract][Full Text] [Related]
11. Human monoclonal antibody to tumor-associated ganglioside GD2.
Katano M; Saxton RE; Irie RF
J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
[TBL] [Abstract][Full Text] [Related]
12. Immunologic problems and perspectives in the therapeutic use of monoclonal antibodies in nephrology.
Bach JF; Chatenoud L
Adv Nephrol Necker Hosp; 1985; 14():365-88. PubMed ID: 3919539
[No Abstract] [Full Text] [Related]
13. GD3 ganglioside antibody augments tumoricidal capacity of canine blood mononuclear cells by induction of interleukin 12.
Helfand SC; Dickerson EB; Munson KL; Padilla ML
Cancer Res; 1999 Jul; 59(13):3119-27. PubMed ID: 10397254
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
[TBL] [Abstract][Full Text] [Related]
16. Response to monoclonal antibodies in melanoma: specific or non-specific?
Knuth A
Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1285-8. PubMed ID: 3830212
[No Abstract] [Full Text] [Related]
17. Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner.
López-Requena A; Bestagno M; Mateo de Acosta C; Cesco-Gaspere M; Vázquez AM; Pérez R; Burrone OR
Mol Immunol; 2007 Apr; 44(11):2915-22. PubMed ID: 17316805
[TBL] [Abstract][Full Text] [Related]
18. Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside.
Hellström I; Brankovan V; Hellström KE
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1499-502. PubMed ID: 3856277
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside.
Welte K; Miller G; Chapman PB; Yuasa H; Natoli E; Kunicka JE; Cordon-Cardo C; Buhrer C; Old LJ; Houghton AN
J Immunol; 1987 Sep; 139(6):1763-71. PubMed ID: 2887619
[TBL] [Abstract][Full Text] [Related]
20. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
Helfand SC; Hank JA; Gan J; Sondel PM
Cell Immunol; 1996 Jan; 167(1):99-107. PubMed ID: 8548851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]